Clopidogrel with or without Omeprazole in Coronary Artery Disease
Deepak L. Bhatt(Mount Sinai Hospital), Christopher P. Cannon(Brigham and Women's Hospital), Mark A. Goldsmith, Thomas Shook, Charles F. Contant, Benjamin M. Scirica(Brigham and Women's Hospital), Marc Cohen(Newark Beth Israel Medical Center), Thomas J. Schnitzer, Pablo Lapuerta(Inserm), Loren Laine(VA Connecticut Healthcare System), Sabina A. Murphy(Brigham and Women's Hospital), Byron Cryer
Cited by 1,230
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k